Global Health & Biotech Archives | Page 8 of 291 | Be Korea-savvy

Archive by category Global Health & Biotech

Philips launches next-generation web-based diagnostic viewer for fast, secure imaging data access anywhere

Philips launches next-generation web-based diagnostic viewer for fast, secure imaging data access anywhere

November 24, 2025 New viewer offers full radiology capabilities, interfaces with AI and interactive reporting module to streamline workflows Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Management 15, the next generation of Philips Vue PACS, including a zero-footprint, web diagnostic viewer [1] that [...]

Enlivex Announces $212,000,000 Private Placement to Initiate World’s First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board

Enlivex Announces $212,000,000 Private Placement to Initiate World’s First Prediction Markets Digital Asset Treasury Strategy, via RAIN token Accumulation, and the Appointment of Matteo Renzi, Former Prime Minister of Italy, to its Board

- Upon the closing of the private placement, Enlivex will adopt the world’s first RAIN prediction markets token digital asset treasury strategy, via RAIN token accumulation. - RAIN is a fully decentralized predictions and options protocol that redefines predictive market ecosystems and provides a powerful platform for on-chain market creation – built for transparency, automation, [...]

Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi’s 2025 Global Healthcare Conference in December

Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi’s 2025 Global Healthcare Conference in December

TEL AVIV, Israel, Nov. 21, 2025 (Korea Bizwire) – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva’s President and CEO, and other members of executive management will present at three upcoming investor conferences in December as follows: 8th Annual Evercore Healthcare Conference Wednesday, December 3, 2025, at 8:20 A.M. [...]

Medela’s 2025 Global Breastfeeding & Lactation Symposium Series Unites Experts Across Three Continents to Advance Maternal and Infant Health

Medela’s 2025 Global Breastfeeding & Lactation Symposium Series Unites Experts Across Three Continents to Advance Maternal and Infant Health

The 17th edition of the renowned series convenes international researchers and healthcare providers, sharing new insights in lactation science, neonatal care, and human milk research Baar, Switzerland, Nov. 20, 2025 (Korea Bizwire) – Medela, a global leader in breast milk and healthcare technology, continues its legacy of advancing lactation science and clinical education through its 2025 Global Breastfeeding [...]

CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally

CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally

Curium and CapVest have announced the recapitalization of Curium via a new Continuation Vehicle The transaction values Curium at circa $7 billion, representing the largest transaction in nuclear medicine globally The recapitalization will accelerate Curium’s strategy to launch innovative, life-changing diagnostic and therapeutic solutions for cancer patients around the world BOSTON, Nov. 20, 2025 (Korea [...]

Boehringer Ingelheim obtains two EU CVMP positive opinions for avian influenza vaccines VAXXITEK® HVT+IBD+H5 and VAXXINACT® H5

Boehringer Ingelheim obtains two EU CVMP positive opinions for avian influenza vaccines VAXXITEK® HVT+IBD+H5 and VAXXINACT® H5

The European Medicines Agency’s (EMA’s) Committee for Veterinary Medicinal Products (CVMP) has adopted positive opinions for two Boehringer poultry vaccines against the highly pathogenic H5 avian influenza virus1. VAXXITEK® HVT+IBD+H5 is the first trivalent vaccine offering combined protection against Marek’s disease, Infectious Bursal Disease and H5 avian influenza in chickens and turkeys in one single [...]

New Global Study: Dangerous Nighttime Heat Rising in 83% of Global Cities Analyzed, Becoming More Oppressive, And More Frequent

New Global Study: Dangerous Nighttime Heat Rising in 83% of Global Cities Analyzed, Becoming More Oppressive, And More Frequent

WASHINGTON, Nov. 19, 2025 (Korea Bizwire) – While leaders have been focusing on avoiding breaching the +1.5°C threshold of the Paris Agreement, a sweeping new scientific analysis of the most dangerous summer weather conditions across 100 major global cities revealed that minimum nighttime temperatures have been rising up to 10 times faster than daytime average [...]

Asia Front and Centre: CAPHRA Powers Regional Voice at GoodCOP 2.0

Asia Front and Centre: CAPHRA Powers Regional Voice at GoodCOP 2.0

GENEVA, Nov. 20, 2025 (Korea Bizwire) – The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) is celebrating the successful “Asia Day” event at the GoodCOP 2.0 held in Geneva. The event, held during the same week as the FCTC COP11 brought together consumer advocates, public health experts, medical professionals, and policymakers to highlight [...]

Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry 4.0, Smart Manufacturing, Digital Health and Biotech Breakthroughs for Pharma’s Biggest Challenges

Teva Launches Rise: A Global Open Innovation Platform to Accelerate AI, Industry 4.0, Smart Manufacturing, Digital Health and Biotech Breakthroughs for Pharma’s Biggest Challenges

First cohort features 7 real-world challenges across R&D, manufacturing and supply chain, commercial and medical affairs  Teva’s first-ever global innovation platform aims to accelerate patient impact and drive business transformation, as part of its Pivot to Growth Strategy Rise will enable startups and tech players worldwide to validate their solutions in real-world settings, scaling impact [...]

Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer

Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer

VANCOUVER, British Columbia, Nov. 18, 2025 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, multifunctional biotherapeutics today announced the appointment of Scott Platshon as Acting Chief Investment Officer. Mr. Platshon will report directly to Zymeworks’ Chair and Chief Executive Officer, Kenneth [...]